Search

Analyst and Investor Event

Webcast

… Analyst and Investor Event Analyst and Investor Event on Wednesday, December 11, 2024 ProQR will …

december 11, 2024
ProQR Announces Presentations and Investor & Analyst Event at the North American Cystic Fibrosis Conference

Press release

LEIDEN, the Netherlands, Oct. 24, 2017 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.

oktober 24, 2017
ProQR Therapeutics to Host Virtual Analyst and Investor Event on December 11, 2024

Press release

LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 05, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.

december 05, 2024
ProQR R&D day Highlights Progress on Pipeline and Introduces Axiomer®, a novel proprietary RNA Technology

Press release

… provide an update on its product candidates today at an investor event, and introduce Axiomer®, a novel RNA platform …

juni 15, 2017
ProQR Announces Year End 2024 Operating and Financial Results

Press release

Axiomer™ ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program AX-0810 targeting NTCP for Cholestatic diseases Company expects up to four clinical data readouts in 2025 and 2026 across multi

maart 13, 2025
ProQR Announces Third Quarter 2024 Operating and Financial Results

Press release

… program to enter the clinic Company to host virtual Investor and Analyst Event in December to highlight translational data and … diseases. ProQR will hold a virtual Analyst and Investor Event in December to highlight translational …

november 07, 2024